Neopenda
Techstars '18Techstars '18Chicago, US · Founded 2015 · Delaware corporation · 14 employees on LinkedIn · 4 known investors
Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.
Founders & leadership
Neopenda was founded in 2015 by Sona Shah and Teresa Cauvel.
SS
Sona ShahCEO and Founder
TC
Teresa CauvelCTO and Founder
Board
ZS
Zachary SeavernsBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$2M disclosed across 8 rounds · 2018–2026
▶$215KraisedAug 2026 · 8 investors · BiotechnologyRule 506(b)
▶$215KraisedAug 2026 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sona ShahExecutive Officer, Director
- Zachary SeavernsDirector
- Offering amount
- $500K
- Amount sold
- $215K
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35KraisedMay 2026 · 1 investors · BiotechnologyRule 506(b)
▶$35KraisedMay 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary SeavernsDirector
- Teresa CauvelExecutive Officer, Director
- Sona ShahExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $35K
- Minimum investment
- $5K
- Proceeds to insiders
- $150K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedNov 2024 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedNov 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sona ShahExecutive Officer, Director
- Teresa CauvelExecutive Officer, Director
- Zachary SeavernsDirector
- Offering amount
- $1.5M
- Amount sold
- $200K
- Minimum investment
- $5K
- Proceeds to insiders
- $375K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedJan 2024 · 5 investors · BiotechnologyRule 506(b)
▶$700KraisedJan 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Teresa CauvelExecutive Officer, Director
- Sona ShahExecutive Officer, Director
- Zachary SeavernsDirector
- Offering amount
- $1.5M
- Amount sold
- $700K
- Minimum investment
- $10K
- Proceeds to insiders
- $240K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$252KraisedJun 2020 · 4 investors · BiotechnologyRule 506(b)
▶$252KraisedJun 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary SeavernsDirector
- Teresa CauvelExecutive Officer, Director
- Sona ShahExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $252K
- Minimum investment
- $25K
- Proceeds to insiders
- $215K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$410KraisedMar 2019 · 3 investors · BiotechnologyRule 506(b)
▶$410KraisedMar 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sona ShahExecutive Officer, Director
- Teresa CauvelExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $410K
- Proceeds to insiders
- $180K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$125KraisedAug 2018 · 2 investors · BiotechnologyRule 506(b)
▶$125KraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Teresa CauvelExecutive Officer, Director
- Sona ShahExecutive Officer, Director
- Offering amount
- $125K
- Amount sold
- $125K
- Minimum investment
- $25K
- Proceeds to insiders
- $42K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$20KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$20KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sona ShahExecutive Officer, Director
- Teresa CauvelExecutive Officer, Director
- Offering amount
- $20K
- Amount sold
- $20K
- Minimum investment
- $20K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Neopenda do?
- Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.
- Who founded Neopenda?
- Neopenda was founded by Sona Shah, Teresa Cauvel in 2015.
- Who are Neopenda's investors?
- Neopenda's investors include Connetic Ventures, Founders Factory Africa, Techstars, Villgro Africa.
- How much funding has Neopenda raised?
- Neopenda has disclosed $2M raised across 8 rounds.
- Where is Neopenda headquartered?
- Neopenda is headquartered in Chicago, US.